Coppell Advisory Solutions’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,881
Closed -$310K 77
2025
Q4
$310K Buy
3,881
+520
+15% +$41K 0.03% 326
2025
Q3
$254K Buy
3,361
+360
+12% +$24.7K 0.03% 351
2025
Q2
$206K Buy
+3,001
New +$197K 0.02% 352
2025
Q1
Sell
-1,282
Closed -$56.3K 652
2024
Q4
$56.3K Buy
1,282
+189
+17% +$10.6K 0.01% 547
2024
Q3
$67.1K Buy
1,093
+461
+73% +$26.9K 0.01% 477
2024
Q2
$37.3K Buy
+632
New +$39.5K 0.01% 569
2023
Q4
$65.2K Buy
826
+687
+494% +$48.9K 0.01% 439
2023
Q3
$13K Sell
139
-109
-44% -$7.72K ﹤0.01% 570
2023
Q2
$17.1K Buy
+248
New +$17.6K ﹤0.01% 586
2023
Q1
Sell
-139
Closed -$13K 394
2022
Q4
$13K Buy
+139
New +$13.4K ﹤0.01% 573

Other funds holding CVS

Coppell Advisory Solutions's CVS Position: Q1 2026 in Review

Coppell Advisory Solutions sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,881 shares — an estimated $310K sold.

Coppell Advisory Solutions first reported a position in CVS in Q4 2022 and held it in 10 quarters. The position peaked at $310K in Q4 2025. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Coppell Advisory Solutions reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Coppell Advisory Solutions sold 3,881 CVS Health shares in Q1 2026, an estimated $310K.
  • Coppell Advisory Solutions first reported a position in CVS Health in Q4 2022 and held it in 10 quarters.
  • Coppell Advisory Solutions's CVS Health position peaked at $310K in Q4 2025.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Coppell Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.